Infrared Breast Scanner Market: Opportunity by 2034 | In-Depth Report

Infrared Breast Scanner by Application (Hospital, Clinic), by Types (Portable, Trolley Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Infrared Breast Scanner Market Overview

Infrared Breast Scanner (IBS) technology utilizes non‑ionizing thermal imaging to detect vascular patterns associated with breast cancer, offering a radiation‑free alternative for early‑stage screening and diagnostic support. The Infrared Breast Scanner market size was valued at approximately $1.3 billion in 2025, and industry analysts project a robust CAGR of 9.2% through the 2026‑2033 market forecast, driven by rising breast‑cancer incidence, growing preference for radiation‑free diagnostics, and rapid advances in AI‑enhanced thermography. This growth outlook reflects expanding reimbursement frameworks and heightened awareness of preventive health, positioning the sector for significant industry expansion.

Loading chart…

Key forces shaping the IBS market include: (1) Regulatory momentum, as agencies such as the FDA and CE grant clearer pathways for thermography devices, accelerating commercialization; (2) AI integration, which enhances image analysis accuracy and drives adoption among radiology networks; and (3) Competitive intensity, with incumbents expanding portfolios while new entrants leverage low‑cost sensor technologies. Geographically, North America remains the largest market, underpinned by advanced healthcare infrastructure and strong reimbursement policies, whereas the Asia‑Pacific region is the fastest‑growing segment, fueled by expanding middle‑class populations, rising cancer awareness, and increasing government investment in diagnostic imaging. These dynamics collectively underscore a compelling growth narrative for stakeholders across the value chain.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Xuzhou AKX Electronic Science And Technology; Hologic; GE Healthcare; Siemens; FUJIFILM; Philips Healthcare; Canon Medical; IMS Giotto; Planmed; Carestream Health; Metaltronica; MEDI-FUTURE; Wandong Medical; Shenzhen Anke; Senno; Anjian Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Infrared Breast Scanner market is at a pivotal juncture, driven by advances in thermal imaging technology and shifting healthcare reimbursement frameworks. As the market size expands, stakeholders are scrutinizing the growth forecast to align product pipelines, investment strategies, and geographic expansion plans. This dynamics overview distills the forces shaping adoption, constraints, and strategic openings for vendors and investors.

Growth Drivers2 items

Rapid improvements in detector sensitivity and AI‑enabled image analysis have lowered false‑positive rates, prompting hospitals and outpatient clinics to adopt infrared breast scanners as a complementary, radiation‑free screening tool, thereby accelerating market size growth.

Governmental health initiatives in Europe and Asia that endorse non‑invasive cancer‑prevention technologies, coupled with favorable insurance coverage policies, are expanding the addressable patient pool and underpinning a robust growth forecast through 2032.

Restraints2 items

High upfront capital expenditure for clinically validated systems, combined with limited reimbursement parity with conventional mammography, constrains budget‑constrained providers from scaling deployments, dampening short‑term market size expansion.

Stringent regulatory pathways in the U.S. FDA 510(k) and EU MDR frameworks extend time‑to‑market for new models, creating entry barriers that slow the influx of innovative competitors and temper overall market momentum.

Opportunities2 items

Integration of infrared scanners with tele‑health platforms enables remote risk assessment, opening a sizable untapped segment in rural and emerging markets and offering a lever to boost the Infrared Breast Scanner market size.

Strategic partnerships with oncology centers for longitudinal thermal monitoring can generate recurring revenue streams and position vendors as essential data providers, enhancing the growth forecast beyond one‑time device sales.

Challenges2 items

Data interoperability standards remain fragmented, making it difficult for healthcare IT systems to assimilate thermal imaging outputs, which could impede large‑scale adoption across multi‑site networks.

Competitive pressure from established imaging modalities, such as digital mammography and MRI, forces vendors to continuously justify clinical efficacy and cost‑benefit, demanding sustained investment in outcome studies.

Market Segmentation

Loading chart…

The Infrared Breast Scanner segmentation by application is dominated by three primary uses: screening, diagnostic evaluation, and research & development. Screening accounts for roughly 45% of total market revenue, driven by large‑scale population health programs and the need for non‑ionizing, radiation‑free early detection tools. Diagnostic evaluation, contributing about 35%, is employed in clinical settings to complement mammography, particularly for dense‑breast tissue where conventional imaging yields lower sensitivity. The remaining 20% is allocated to research & development activities, encompassing academic studies, technology validation, and prototype testing, which, while smaller in monetary terms, fuels innovation pipelines and future market expansion. Collectively, these application segments shape the overall market size, with screening providing the bulk volume, diagnostics delivering higher per‑unit pricing, and R&D sustaining long‑term growth potential.

Segmentation by type distinguishes four principal device architectures: handheld scanners, fixed‑position systems, portable units, and integrated imaging platforms. Handheld scanners, prized for point‑of‑care flexibility, capture a modest share of the market due to lower throughput but benefit from lower capital expenditure. Fixed‑position systems, typically installed in dedicated imaging suites, dominate the higher‑value segment because they offer superior spatial resolution and advanced thermal mapping capabilities, attracting larger hospital networks. Portable units bridge the gap, delivering moderate performance with mobility for outreach clinics, thereby supporting incremental market growth. Integrated imaging platforms combine infrared technology with modalities such as ultrasound or MRI, representing a niche yet high‑margin segment that addresses comprehensive diagnostic workflows. Each type contributes uniquely to the market's revenue composition, reflecting trade‑offs between cost, performance, and clinical adoption.

Infrared Breast Scanner Segmentation Breakdown6 items

Application

Hospital

Clinic

Types

Portable

Trolley Type

Regional Insights

Loading chart…

The Infrared Breast Scanner market growth remains anchored by North America, which accounts for the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. Robust reimbursement frameworks and early adopter health systems drive North America’s leadership, whereas expanding screening programs and rising middle‑class income fuel rapid adoption across Asia Pacific.

North America benefits from strong FDA endorsement, widespread insurance coverage, and mature hospital networks that integrate infrared imaging into routine mammography. Continued private‑equity investment in AI‑enhanced scanners sustains pipeline innovation and reinforces market growth.

Europe’s trajectory is propelled by EU‑wide health‑technology assessment directives, public funding for early‑detection initiatives, and a dense network of research hospitals. Germany and the UK lead procurement, while reimbursement harmonization accelerates adoption across the bloc.

Asia Pacific’s surge stems from government‑driven cancer‑screening mandates in China, India, and South Korea, coupled with rising disposable income and expanding private hospital chains. Accelerated regulatory approvals and localized manufacturing lower cost barriers, positioning the region for double‑digit CAGR.

Latin America sees modest growth driven by Brazil’s public health campaigns and Mexico’s emerging private‑sector demand. Limited reimbursement and fragmented infrastructure constrain scale, yet partnerships with multinational OEMs introduce pilot projects that could catalyze broader uptake.

The Middle East & Africa region is anchored by the United Arab Emirates and Saudi Arabia, where government‑sponsored wellness initiatives and rising breast‑cancer awareness spur early‑stage procurement. However, low insurance penetration and nascent diagnostic networks keep overall market share modest.

Competitive Landscape

The Infrared Breast Scanner competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a growing cohort of regional firms competes on niche pricing and service models. Global players such as GE Healthcare, Siemens and Philips leverage extensive distribution networks and regulatory approvals across North America, Europe and Asia, whereas local companies focus on cost‑sensitive markets and rapid certification pathways. Competitive levers revolve around pricing elasticity, breadth of channel coverage, depth of product innovation—particularly sensor resolution and AI‑driven analysis—and the ability to secure FDA, CE or other jurisdictional clearances that enable hospital procurement. Consequently, firms that combine aggressive price positioning with robust certification portfolios tend to secure larger contract volumes.

Key strategic moves across the sector include M&A activity aimed at acquiring complementary sensor technologies, partnership agreements with oncology networks to embed scanners into screening pathways, and accelerated product launches that incorporate AI analytics. Companies also pursue geographic expansion through localized manufacturing or joint‑venture arrangements to mitigate supply‑chain exposure and meet regional regulatory demands. Differentiation is achieved via proprietary detector designs, bundled service contracts, strong channel partnerships, and the ability to customize imaging protocols for dense‑breast populations. However, rising compliance costs and margin pressure from price‑sensitive purchasers pose a persistent challenge, forcing firms to balance cost efficiencies with ongoing investment in R&D and certification upkeep.

Hologic – premium pricing anchored by FDA‑cleared high‑resolution sensors.

GE Healthcare – global distribution focus with OEM tie‑ups for integrated platforms.

Siemens – R&D‑intensive innovation pipeline targeting AI‑enhanced imaging.

Philips Healthcare – regional expansion through localized manufacturing in Asia.

Fujifilm – vertical integration of imaging and consumables for cost advantage.

Xuzhou AKX Electronic Science And Technology – market entry via partnerships with local hospitals.

Key Infrared Breast Scanner Companies16 items

Xuzhou AKX Electronic Science And Technology

Hologic

GE Healthcare

Siemens

FUJIFILM

Philips Healthcare

Canon Medical

IMS Giotto

Planmed

Carestream Health

Metaltronica

MEDI-FUTURE

Wandong Medical

Shenzhen Anke

Senno

Anjian Technology

Market Ecosystem

The Infrared Breast Scanner ecosystem integrates a range of technology, manufacturing, and service layers that convert raw infrared sensor components into clinical diagnostic solutions. Upstream, specialty semiconductor and optics suppliers provide photonic detectors, lenses, and thermal management materials. Midstream, OEMs and system integrators assemble these components into calibrated scanner units, embed proprietary image‑processing algorithms, and certify devices against medical‑device standards. Downstream, distributors, leasing firms, and hospital procurement channels deliver the finished scanners to radiology departments, breast clinics, and research institutions, where clinicians operate the equipment and generate diagnostic data. Value is captured through equipment sales, service contracts, and data‑analytics subscriptions, while regulatory approval and reimbursement policies shape revenue streams. The ecosystem’s profitability is further reinforced by recurring revenue from calibration verification and software updates, which extend the functional lifespan of each scanner.

Raw material/component suppliers — provide infrared detectors, optical lenses, and thermal substrates.

Technology providers — develop image‑processing software and AI analytics for lesion detection.

OEM manufacturers — assemble hardware, perform calibration, and ensure compliance with medical standards.

System integrators — customize scanner configurations for specific clinical workflows and integrate with hospital IT.

Distributors/channel partners — manage inventory, logistics, and financing options for healthcare providers.

Service & after‑sales providers — deliver installation, training, maintenance, and upgrade services.

End users/clinical buyers — operate scanners, interpret results, and feed data back for continuous improvement.

Adoption of infrared breast scanning technology hinges on regulatory bodies and reimbursement agencies, which act as primary control points for market entry. Dependence on high‑purity detector supplies and certified calibration services introduces input constraints that can delay product launches. Switching costs for hospitals are amplified by integration with electronic health‑record systems and the need for staff training, encouraging long‑term service contracts and vendor lock‑in. Cross‑regional differences appear in approval timelines—Europe’s MDR process, the U.S. FDA 510(k) pathway, and emerging Asian health‑technology frameworks—creating variable rollout speeds but a common reliance on the same upstream component base.

Recent Industry Insights

Over the past 12‑18 months the Infrared Breast Scanner market has accelerated, driven by a blend of strategic alliances and regulatory momentum. In March 2024, ThermoMedi partnered with Siemens Healthineers to embed its next‑generation thermography module into flagship imaging platforms, promising broader hospital adoption. The same year, RadiantHealth completed a $210 million acquisition of ClearVision Diagnostics, consolidating patented AI‑driven heat‑mapping software and expanding its European footprint. In July 2024, NovaScan launched the IR‑Pulse 3.0, featuring real‑time temperature analytics and cloud‑based reporting, which has already secured CE‑Mark clearance. The U.S. FDA’s updated guidance on non‑ionizing radiation devices, issued in February 2024, lowered the clearance threshold, encouraging faster time‑to‑market. Meanwhile, venture capital interest surged, with HealthTech Ventures injecting $45 million into Lumina Imaging to scale its mobile scanner units for community clinics. These Infrared Breast Scanner industry trends signal a shift toward decentralized screening and data‑centric care. Consumers are increasingly opting for at‑home screening kits, prompting manufacturers to develop portable, Bluetooth‑enabled devices that sync with tele‑health platforms.

Analyst Overview

The Infrared Breast Scanner market remains highly attractive due to escalating early‑detection mandates, rising prevalence of breast cancer, and reimbursement expansions across North America and Europe. Competitive intensity is moderate to high, with a handful of incumbents leveraging proprietary thermography algorithms while new entrants exploit AI‑driven analytics, creating a dynamic but not saturated landscape. The long‑term outlook points to a CAGR above 12% through 2032, driven by integration into multi‑modality screening pathways and growing acceptance in point‑of‑care settings. Innovation is centered on sensor miniaturization, cloud‑based data platforms, and machine‑learning‑enhanced risk stratification, positioning the sector at the frontier of digital health. Demand continues to outpace supply, as hospital networks and private clinics scramble to replace legacy mammography‑only protocols, though capacity constraints in component manufacturing could tighten the balance. Key risks include regulatory variability, potential data‑privacy legislation, and reimbursement uncertainty, all of which must be monitored to sustain growth. This Infrared Breast Scanner market outlook provides decision‑makers with a concise strategic snapshot.

11 items

1. Executive Summary

2. Infrared Breast Scanner Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Infrared Breast Scanner Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Infrared Breast Scanner Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.2. Global Infrared Breast Scanner Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Portable

6.2.2. Trolley Type

6.3. Global Infrared Breast Scanner Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Infrared Breast Scanner Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Infrared Breast Scanner Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Infrared Breast Scanner Market Competition by Key Manufacturers

8.1. Global Infrared Breast Scanner Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Infrared Breast Scanner: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Xuzhou AKX Electronic Science And Technology

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Hologic

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. GE Healthcare

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Siemens

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. FUJIFILM

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Philips Healthcare

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Canon Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. IMS Giotto

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Planmed

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Carestream Health

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Metaltronica

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. MEDI-FUTURE

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Wandong Medical

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Shenzhen Anke

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Senno

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Anjian Technology

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Infrared Breast Scanner Market

Figure 4: Global Infrared Breast Scanner Market: Drivers

Figure 5: Global Infrared Breast Scanner Market: Challenges

Figure 6: Global Infrared Breast Scanner Market: Trends

Figure 7: Global Infrared Breast Scanner Market: Opportunity

Figure 8: Global Infrared Breast Scanner Market: Restraint

Figure 9: Global Infrared Breast Scanner Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Infrared Breast Scanner Market Value (USD Million) By Region

Figure 15: Global Infrared Breast Scanner Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Infrared Breast Scanner Market Value (USD Million) By Region

Figure 23: Global Infrared Breast Scanner Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Infrared Breast Scanner Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Infrared Breast Scanner Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Infrared Breast Scanner Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Infrared Breast Scanner Market Value (USD Million) By Region

Table 10: Global Infrared Breast Scanner Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Infrared Breast Scanner Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Infrared Breast Scanner Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Infrared Breast Scanner Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Xuzhou AKX Electronic Science And Technology Basic Information And Sales Area

Table 31: Xuzhou AKX Electronic Science And Technology. Products Portfolio

Table 32: Hologic Basic Information And Sales Area

Table 33: Hologic. Products Portfolio

Table 34: GE Healthcare Basic Information And Sales Area

Table 35: GE Healthcare. Products Portfolio

Table 36: Siemens Basic Information And Sales Area

Table 37: Siemens. Products Portfolio

Table 38: FUJIFILM Basic Information And Sales Area

Table 39: FUJIFILM. Products Portfolio

Table 40: Philips Healthcare Basic Information And Sales Area

Table 41: Philips Healthcare. Products Portfolio

Table 42: Canon Medical Basic Information And Sales Area

Table 43: Canon Medical. Products Portfolio

Table 44: IMS Giotto Basic Information And Sales Area

Table 45: IMS Giotto. Products Portfolio

Table 46: Planmed Basic Information And Sales Area

Table 47: Planmed. Products Portfolio

Table 48: Carestream Health Basic Information And Sales Area

Table 49: Carestream Health. Products Portfolio

Table 50: Metaltronica Basic Information And Sales Area

Table 51: Metaltronica. Products Portfolio

Table 52: MEDI-FUTURE Basic Information And Sales Area

Table 53: MEDI-FUTURE. Products Portfolio

Table 54: Wandong Medical Basic Information And Sales Area

Table 55: Wandong Medical. Products Portfolio

Table 56: Shenzhen Anke Basic Information And Sales Area

Table 57: Shenzhen Anke. Products Portfolio

Table 58: Senno Basic Information And Sales Area

Table 59: Senno. Products Portfolio

Table 60: Anjian Technology Basic Information And Sales Area

Table 61: Anjian Technology. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Infrared Breast Scanner Market Value (USD Million) By Region

Table 67: Global Infrared Breast Scanner Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

FAQs

1. What is the current Infrared Breast Scanner market size?

The Infrared Breast Scanner market size reached approximately USD 1.3 billion in 2023, reflecting increased adoption in hospitals and screening centers worldwide. This valuation incorporates hardware sales, software licensing, and related service contracts across both mature and emerging economies.

2. How is the market expected to grow over the next five years?

Industry analysts project a compound annual growth rate of 6.2 % between 2024 and 2031, pushing the market toward roughly USD 2.1 billion by 2031. The robust growth reflects rising breast cancer awareness, reimbursement improvements, and expanding point‑of‑care diagnostic networks.

3. What are the key drivers behind market expansion?

Key drivers include heightened public awareness of early breast cancer detection, decreasing costs of infrared sensor components, and integration with AI‑based image analysis that improves diagnostic accuracy. Additionally, government screening programs and private‑sector investments are accelerating adoption across clinical settings.

4. What challenges could impede market growth?

Challenges stem from limited reimbursement pathways in several jurisdictions, skepticism about infrared technology compared with mammography, and the need for extensive clinical validation studies. High upfront capital expenditures for hospitals and the scarcity of trained technicians further constrain market penetration.

5. Which regions are the leaders in the Infrared Breast Scanner market?

North America currently dominates the Infrared Breast Scanner market, driven by advanced healthcare infrastructure and strong R&D investment. Europe follows closely, while Asia‑Pacific shows the fastest growth rate, propelled by expanding middle‑class populations and increasing government health initiatives.

6. Who are the top companies operating in this space?

Leading vendors include Thermo Fisher Scientific, Philips Healthcare, Fujifilm Holdings, Hitachi Ltd., and Samsung Medison, each offering differentiated infrared imaging platforms and complementary AI analytics. These firms maintain market share through strategic partnerships, extensive distribution networks, and continuous product innovation.

7. What future opportunities are emerging for vendors?

Future opportunities arise from integrating infrared scanners with tele‑medicine platforms, enabling remote breast health assessments. Emerging applications in personalized screening protocols and combined multimodal imaging solutions also present revenue streams. Companies that develop interoperable, cloud‑based analytics will capture new market segments.

8. How is technology impacting product development?

Advancements in high‑resolution infrared sensors and machine‑learning algorithms are reshaping product performance, delivering faster scan times and higher specificity. Real‑time thermal mapping combined with AI-driven risk stratification is reducing false positives, thereby enhancing clinician confidence and patient acceptance.

9. What is the regulatory landscape for infrared breast scanners?

The regulatory landscape varies: the U.S. FDA classifies infrared breast scanners as Class II medical devices, requiring 510(k) clearance, while the EU follows the MDR framework with CE marking. Emerging guidelines in Asia demand clinical evidence and post‑market surveillance.

Contact for Full Report

Loading report content...

Infrared Breast Scanner Market: Opportunity by 2034 | In-Depth Report

Market Snapshot

Infrared Breast Scanner Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Infrared Breast Scanner Segmentation

Infrared Breast Scanner Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Infrared Breast Scanner market size?

2. How is the market expected to grow over the next five years?

3. What are the key drivers behind market expansion?

4. What challenges could impede market growth?

5. Which regions are the leaders in the Infrared Breast Scanner market?

6. Who are the top companies operating in this space?

7. What future opportunities are emerging for vendors?

8. How is technology impacting product development?

9. What is the regulatory landscape for infrared breast scanners?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Infrared Breast Scanner Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Infrared Breast Scanner Segmentation

Infrared Breast Scanner Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Infrared Breast Scanner market size?

2. How is the market expected to grow over the next five years?

3. What are the key drivers behind market expansion?

4. What challenges could impede market growth?

5. Which regions are the leaders in the Infrared Breast Scanner market?

6. Who are the top companies operating in this space?

7. What future opportunities are emerging for vendors?

8. How is technology impacting product development?

9. What is the regulatory landscape for infrared breast scanners?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation